The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
Boehringer Ingelheim's product portfolio covers the following main indications:
Chronic Obstructive Pulmonary Disease (COPD)
Restless Legs Syndrome
Stroke Prevention in AF